Moderna

News

Life science leaders sign new ‘Biotech Social Pact’ for Europe

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

The EMA's human medicines committee (CHMP) has recommended authorisation of two COVID-19 vaccines from Moderna and Pfizer/BioNTech that include sequences coding for Omicron spike protein as

News

FDA clears bivalent Omicron shots from Pfizer, Moderna

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicr

R&D

Automation in the clinical laboratory. Pipetting robot laboratory. Medicine robotics. Research and science background

Expectations rise for gene therapy to change treatment lands...

After a recent approval, there are now three gene therapies available on the US market.

News

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

News

Digital innovation drives vaccine development

Pfizer hoping for pole position in RSV vaccine contest

Pfizer is aiming to be first on the grid in the race to being a vaccine against respiratory syncytial virus (RSV) to market, after reporting results from a phase 3 trial of the jab in older

Digital

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Baillie Gifford, Moderna’s largest shareholder, shares inves...

Jack Torrance, investment specialist for Baillie Gifford's Health Innovation Fund, tells us how the organisation ensures its investments will have the most significant positive impact on al

EMA panel backs COVID-19 vaccines targeting Omicron BA.1

FDA clears bivalent Omicron shots from Pfizer, Moderna

Expectations rise for gene therapy to change treatment lands...

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

Pfizer hoping for pole position in RSV vaccine contest

Baillie Gifford, Moderna’s largest shareholder, shares inves...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Moderna

Editor's Picks